Join Us!
Lyfebulb invites you to join our patient conference, “Empowering Lives: State of Transplantation.” This event brings together everyone involved in the transplant journey—recipients, donors, care partners, doctors, and industry experts with the goal to improve the quality of life and outcomes for everyone. We’re here to share stories, learn from experts, discuss challenges, and find solutions.
Our event on October 4, 2024 at NYU Langone Health in New York City will include:
- Inspirational Talks: Hear from experts in the field of transplantation
- Engaging Panels: Join discussions on important topics from both the patient and provider perspective, such as new treatments, care management, and future innovations in transplantation
- Networking Opportunities: Connect with others who understand your journey
- Contribute to the Future: Offer your perspective through questions to panels and responses to a survey
- Peer-to-Peer Meet-Up: Meet your fellow transplant peers in a closed session led by our TransplantLyfe Community managers (patients, donors and care partners only)
Agenda
9:00 – 9:10 AM
Welcome Remarks & Introductions
Karin Hehenberger, MD, PhD, Lyfebulb and Robert Montgomery, MD, DPhil, NYU Langone Transplant Institute
9:10 – 9:30 AM
My Transplant Journey by Jeanmarie Ferguson: Living with a Transplant
9:30 – 10:00 AM
How to Own the Organ Selection Process by Michael Goldstein, MD, Hackensack Meridian Health
10:00 – 10:15 AM
The Perfect Match by Bonnie Lonze, MD, PhD, NYU Langone Transplant Institute
10:15 – 10:45 AM
How to Optimize Current Therapies by David Cohen, MD, Columbia University Irving Medical Center (CUIMC) / NewYork-Presbyterian Hospital
10:45 – 11:15 AM
Celebrities As a Vehicle to Influence Change in Healthcare by Mark Hardy, MD, Columbia University Irving Medical Center (CUIMC) / NewYork-Presbyterian Hospital
11:15 – 11:30 AM
Break
11:30 – 12:00 PM
Fast Tracking Treatment Options: Regulatory Environment and Clinical Endpoints with Eliezer Katz, MD Eledon, Ken Newell, MD, Emory University, moderated by Karin Hehenberger, MD, PhD
12:00 – 12:45 PM
Aiming High: Less Drugs, More Organs: Tolerance by Ken Newell, MD, Emory University, and Xenotransplant by Robert Montgomery, MD, DPhil, NYU Langone Transplant Institute
12:45 – 1:45 PM
Lunch Break with Peer to Peer Meet Up for Patients, Led by Lyfebulb Community Managers
1:45 – 2:15 PM
Treating Patients Today by Nicole Ali, MD, NYU Langone Transplant Institute, and R.J. Crew, MD, CUIMC / NewYork-Presbyterian Hospital
2:15 – 2:45 PM
Ups and Downs in Caring for Your Transplant, Recipient Panel: LaVise McCray, Taryn Servold, and Sam Dey moderated by Leslie Brille, Lyfebulb
2:45 – 3:15 PM
Quality of Life Panel with Anne Lawler, LCSW, Joan Kelly, RN and Jeanmarie Ferguson, moderated by Mark Hardy, MD
3:15 – 3:30 PM
Break
3:30 – 3:45 PM
Mind & Body by Afternoon stretch by Alisha Hiebert, RYT, MBC, TransplantLyfe Community Manager
3:45 – 4:15 PM
The Transplant365 Solution: Vision, objective and demonstration of a new solution
4:15 – 4:30 PM
Closing Remarks
*Post-event mingling (refreshments and snacks)
SPEAKERS
Nicole Ali, MD
Clinical Associate Professor, Department of Medicine at NYU Grossman School of Medicine; Director, Quality, Transplant Institute at NYU Langone Transplant Institute
Russell J. Crew, MD
Assistant Professor of Medicine at NewYork-Presbyterian / Columbia University Irving Medical Center
Michael Goldstein, MD
Director of Organ Transplantation at Hackensack University Medical Center
Mark A. Hardy, MD, PhD (Hon), FACS
Director Emeritus and Founder, Renal and Islet Transplantation, and Surgeon, Abdominal Organ Transplantation and Islets at NewYork-Presbyterian Hospital/Columbia University Medical Center
Karin Hehenberger, MD, PhD
Founder & CEO at Lyfebulb
Eliezer Katz, MD, FACS
Chief Medical Officer at Eledon Pharmaceuticals
Robert Montgomery, MD, PhD
H. Leon Pachter Chair and Professor of Surgery Director at NYU Langone Transplant Institute
Kenneth Newell, MD, PhD
Chief Medical Officer at Eledon Pharmaceuticals
Anne B. Lawler, CSW, LCSW, ACSW, BCD
Assistant Professor of Medicine at NewYork-Presbyterian / Columbia University Irving Medical Center
Thank You To Our Supporters
Eledon Pharmaceuticals is a clinical stage biotechnology company with immunology expertise that is developing therapies to protect and prevent rejection of transplanted organs, as well as to treat amyotrophic lateral sclerosis (ALS). The Company’s lead compound in development is tegoprubart, an anti-CD40L antibody with high affinity for CD40 Ligand (also called “CD154”), a well-validated biological target with broad therapeutic potential.
Memo Therapeutics AG (“MTx”) is a late-stage biotech company translating unique human immune responses into superior medicines through the development of best-in-class antibodies to treat viral infections and cancer.
We are an innovative global healthcare company, driven by one purpose: we chase the miracles of science to improve people’s lives. Our team, across the world, is dedicated to transforming the practice of medicine by working to turn the impossible into the possible. We provide potentially life-changing treatment options and life-saving vaccine protection to millions of people globally, while putting sustainability and social responsibility at the center of our ambitions.
Brought to you by
Lyfebulb
Under the leadership of Dr. Robert Montgomery, the NYU Langone Health Transplant Institute is a national leader in organ transplantation, excelling in heart, kidney, liver, and lung transplants. According to SRTR data, the institute boasts the fastest heart transplant rate in the Northeast, the top kidney program in the country, a 100% one-year liver transplant survival rate, and the highest-ranked lung transplant program in the U.S. These achievements highlight the institute’s expertise in treating complex cases.
